6 |
Han W.M., Avihingsanon A., Rajasuriar R., Tanuma J., Mundhe S., Lee M.-P., Choi J.Y., Pujari S., Chan Y.-J., Somia A., Zhang F., Kumarasamy N., Tek Ng O., Gani Y., Chaiwarith R., Pham T.N., Do C.D., Ditangco R., Kiertiburanakul S., Khol V., Ross J., Jiamsakul A., Ly P.S., Zhao H.X., Han N., Li P.C.K., Lam W., Chan Y.T., Ezhilarasi C., Joshi K., Gaikwad S., Chitalikar A., Sangle S., Mave V., Marbaniang I., Nimkar S., Merati T.P., Wirawan D.N., Yuliana F., Yunihastuti E., Widhani A., Maria S., Karjadi T.H., Oka S., Nishijima T., Na S., Kim J.M., Rudi N.B., Azwa I., Kamarulzaman A., Syed Omar S.F., Ponnampalavanar S., Pasayan M.K., Mationg M.L., Ku W.W., Wu P.C., Ke E., Lim P.L., Lee L.S., Liang D., Gatechompol S., Phanuphak P., Phadungphon C., Phuphuakrat A., Chumla L., Sanmeema N., Sirisanthana T., Praparattanapan J., Nuket K., Khusuwan S., Kantipong P., Kambua P., Nguyen K.V., Bui H.V., Nguyen D.T.H., Nguyen D.T., Ngo A.V., Nguyen L.T., Sohn A.H., Ross J.L., Petersen B., Law M.G., Jiamsakul A., Bijker R., Rupasinghe D. |
CD4/CD8 Ratio Recovery among People Living with HIV Starting with First-Line Integrase Strand Transfer Inhibitors: A Prospective Regional Cohort Analysis |
Journal of Acquired Immune Deficiency Syndromes |
|
The Kirby Institute, UNSW SydneyNSW, Australia; HIV-NAT/Thai Red Cross AIDS Research Centre, Centre of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia; National Center for Global Health and Medicine, Tokyo, Japan; BJ Government Medical College, Sassoon General Hospital, Pune, India; Queen Elizabeth Hospital, Hong Kong, Hong Kong; Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea; Institute of Infectious Diseases, Pune, India; Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine Udayana University, Sanglah Hospital, Bali, Indonesia; Beijing Ditan Hospital, Capital Medical University, Beijing, China; CART CRS, Voluntary Health Services, Chennai, India; Tan Tock Seng Hospital, National Centre for Infectious Diseases, Singapore, Singapore; Hospital Sungai Buloh, Sungai Buloh, Malaysia; Chiang Mai University, Research Institute for Health Sciences, Chiang Mai, Thailand; National Hospital for Tropical Diseases, Hanoi, Viet Nam; Bach Mai Hospital, Hanoi, Viet Nam; Research Institute for Tropical Medicine, Muntinlupa City, Philippines; Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia; TREAT Asia, AmfAR-the Foundation for AIDS Research, Bangkok, Thailand; Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS), VHSInfectious Diseases Medical Centre, VHS, Chennai, India; Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia; University Malaya Medical Centre, Kuala Lumpur, Malaysia; Tan Tock Seng Hospital, Singapore, Singapore; HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand; Research Institute for Health Sciences, Chiang Mai, Thailand; Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand |
U01AI069907; National Institutes of Health, NIH; National Institute of Mental Health, NIMH; National Institute on Drug Abuse, NIDA; National Institute on Alcohol Abuse and Alcoholism, NIAAA; National Heart, Lung, and Blood Institute, NHLBI; National Cancer Institute, NCI; National Institute of Allergy and Infectious Diseases, NIAID; National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD; Depa |
Wolters Kluwer Health |
Q1 |
|
|